Manvel, TX, United States of America

Corazon D Bucana

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Corazon D Bucana. Retrieved from https://idiyas.com/inventor/corazon-d-bucana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Corazon D Bucana: Innovator in Anticancer Treatment Detection

Introduction

Corazon D Bucana is a notable inventor based in Manvel, Texas. She has made significant contributions to the field of cancer research, particularly in the detection of the efficacy of anticancer treatments. Her innovative work has the potential to improve patient outcomes and enhance the effectiveness of cancer therapies.

Latest Patents

Corazon D Bucana holds a patent for "Methods for detecting the efficacy of anticancer treatments." This patent outlines methods for determining the effectiveness of anticancer agents by assessing growth factor receptor phosphorylation levels in samples obtained through non-invasive procedures. The invention also includes techniques for detecting growth factor receptor phosphorylation in hair follicles and other tissues, further advancing non-invasive diagnostic methods.

Career Highlights

Bucana is affiliated with the University of Texas System, where she continues her research and development in cancer treatment methodologies. Her work is characterized by a commitment to improving the understanding and effectiveness of anticancer therapies.

Collaborations

One of her notable collaborators is Isaiah J Fidler, with whom she has worked on various research projects aimed at enhancing cancer treatment detection methods.

Conclusion

Corazon D Bucana's contributions to cancer research through her innovative patent demonstrate her dedication to improving patient care. Her work in developing non-invasive methods for detecting anticancer treatment efficacy is a significant advancement in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…